Status:
COMPLETED
Telmisartan 80mg+Hydrochlorothiazide (HCTZ) 25 mg in Hypertension: an Observational Study
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
18+ years
Brief Summary
It is a national, retrospective , observational study in hypertensive patients treated for at least 8 weeks with the fixed dose combination of telmisartan 80 mg and hydrochlorothiazide 25 mg. The prim...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Hypertensives
- Treated for at least 8 weeks with the fixed dose combination of telmisartan 80 mg and hydrochlorothiazide 25 mg
- Exclusion criteria:
- \- Treated with the combination less than 8 weeks
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
2411 Patients enrolled
Trial Details
Trial ID
NCT00909038
Start Date
May 1 2009
Last Update
June 5 2014
Active Locations (915)
Enter a location and click search to find clinical trials sorted by distance.
1
Boehringer Ingelheim Investigator site 1
Ablon-sur-Seine, France
2
Boehringer Ingelheim Investigator site 2
Achenheim, France
3
Boehringer Ingelheim Investigator site 3
Afa, France
4
Boehringer Ingelheim Investigator site 4
Aiguillon, France